Protective Effect of Chloroform Extract of Cyperus Rotundus against DNBS Induced Inflammatory Bowel Disease in Rats

Authors

  • Johari Sarika Department of Pharmacology, Anand Pharmacy College, Anand, Gujarat, India
  • Gandhi Tejal Department of Pharmacology, Anand Pharmacy College, Anand, Gujarat, India

Abstract

 

The present study was designed to evaluate the effects of Cyperus rotundus on DNBS (Dinitrobenzene sulfonic acid) induced IBD in experimental rats. The experimental protocol (Protocol No. 9012 dated 26th Dec 2009) was approved by Institutional Animal Ethical Committee of Anand Pharmacy College. Colitis was induced with DNBS (180 mg/kg in 50% ethanol) intracolonically in animals on the 11th day of the study. Animals were fasted for 24 h prior to study, given access to water ad libitum. Sprague Dawley rats were randomly allocated to seven groups for the main studies. Group I served as the normal control. Group II served as vehicle control which received 50% ethanol intracolonically on 11th day of the study. Group III served as Model control. Animals of Group IV to VII were given the Standard drug 5-Amino Salicylic Acid (5-ASA) (100 mg/kg), chloroform extract of Cyperus rotundus (CHCR) (600 mg/kg) , CHCR
(800 mg/kg ) and CMC suspension respectively for 18 days once a day orally. Colitis was induced in animals of Group III–VII. During the study body weight, total food intake and water intake of each group was measured daily. Stool consistency was measured for each group daily after induction and scored from 0 to 2, the average score was calculated. On 18th day, blood was collected for the estimation of cortisol. The colon was removed from euthanized rats, length and weight of it was measured. Colon from all the groups was stored in the formalin (10%) for the histopathology study and microscopic scoring. Remaining colon tissues were opened along the antimesentericborder and scored for macroscopic parameters like Colon mucosal Disease index (CMDI). Colon homogenate was prepared and was used for estimation of various biochemical parameters Nitric oxide (NO), Malondialdehyde (MDA), Myeloperoxidase (MPO) and Superoxide dismutase (SOD). DNBS Model control animals showed significant reduction in percent change in body weight, water intake, food intake, SOD, colon length and significant increase colon weight, MDA, MPO, NO, CMDI, DAI and serum Cortisol level. Pretreatment with 5-ASA (100 mg/kg), CHCR (600 mg/kg) and CHCR (800 mg/kg) significantly prevented these changes induced by DNBS. CHCR was found to have anti-inflammatory and antioxidant activities which was beneficial to reduce the severity of the IBD induced by DNBS intracolonically administration in rats. Thus, Cyperus rotundus is effective, safe and economical and can be used as an alternative for the treatment of IBD patients.

 

Keywords: Cyperus rotundus, inflammatory bowel disease, DNBS, 5-Amino Salicylic Acid, anti-inflammatory, antioxidant

Downloads

Published

2019-07-18

Issue

Vol. 4 No. 3 (2014)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.